NEO Stock-Based Compensation
Neogenomics Inc · Stock-Based Compensation
NEO Stock-Based Compensation
Latest reported$28.16Mperiod ending
NEO Stock-Based Comp ($0.00 → $28.16M)
Annual stock-based compensation
High-resolution chart · PNG
NEO stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 41,316,000 | |
| 33,413,000 | |
| 24,633,000 | |
| 24,672,000 | |
| 22,458,000 | |
| 10,212,000 | |
| 10,000,000 | |
| 6,955,000 | |
| 6,441,000 | |
| 5,438,000 | |
| 3,479,000 | |
| 692,000 | |
| 929,000 | |
| 798,000 | |
| 458,000 | |
| 411,000 | |
| 372,951 | |
| 246,180 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |